Information for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131

This information is intended for Colorado Prescribers 

HB 19-1131

MARKETED PRESCRIPTION DRUG COLORADO WAC DISCLOSURE FORM DATE UPDATED
Diabetes Products Form 1/17/2020
Vaccines Form 10/05/2020
ALDURAZYME® (laronidase) Form 1/22/2020
ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein] Form 1/17/2020
AUBAGIO® (teriflunomide) Form 1/17/2020
AVALIDE® (irbesartan/hydrochlorothiazide) Form 1/17/2020
AVAPRO® (irbesartan) Form 1/17/2020
CABLIVI® (caplacizumab-yhdp) Form 1/17/2020
CAPRELSA® (vandetanib) Form 1/17/2020
CERDELGA® (eliglustat) capsules, for oral use Form 1/17/2020
Cerezyme® (imiglucerase for injection) Form 1/17/2020
DUPIXENT® (dupilumab) Injection Form 7/01/2020
ELITEK® (rasburicase) for injection Form 7/01/2020
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] Form 1/17/2020
FABRAZYME® (agalsidase beta) for injection, for intravenous use Form 1/17/2020
JEVTANA® (cabazitaxel) Injection Form 7/01/2020
KEVZARA® (sarilumab) Form 1/17/2020
LEMTRADA® (alemtuzumab) Form 7/01/2020
LIBTAYO® (cemiplimab - rwlc) Form 1/17/2020
LUMIZYME® (alglucosidase alfa) Form 1/17/2020
Mozobil® (plerixafor injection) Form 1/17/2020
MULTAQ® (dronedarone) Form 1/17/2020
SARCLISA® (isatuximab-irfc) injection Form 3/09/2020
Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)] Form 1/17/2020
THYROGEN® (thyrotropin alfa for injection) Form 1/17/2020
ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion Form 1/17/2020

House Bill 19-1131. Published by the General Assembly of the State of Colorado  

Please See Full Prescribing Information, including Boxed Warning, for Aldurazyme, Aubagio, Avalide, Avapro, Caprelsa, Elitek, Jevtana, Kevzara, Lemtrada, Lumizyme, Multaq, Thymoglobulin, Zaltrap